Skip to main content
SpringerLink
Log in

Current Status of Imaging for Adrenal Malignant Involvement

  • Chapter
Imaging in Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 143))

Adrenal masses are relatively common in the general population, with a mean prevalence determined from several large autopsy studies of 2.3 percent [1]. Given the propensity for and the clinical importance of adrenal metastatic involvement, accurate diagnosis of adrenal masses is of particular important in oncologic patients. Fortunately non-invasive radiology can usually determine whether a mass is benign or likely malignant (indeterminate lesion), based on recent research into the imaging characteristics of adrenal masses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149:273–85.

    Article  PubMed  CAS  Google Scholar 

  2. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2006:578–585.

    Google Scholar 

  3. Szolar DH, Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005; 234:479–85.

    Article  PubMed  Google Scholar 

  4. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629–33.

    Article  PubMed  Google Scholar 

  5. Lee M, Hahn P, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415–8.

    PubMed  CAS  Google Scholar 

  6. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996; 166:531–6.

    PubMed  CAS  Google Scholar 

  7. Singer A, Obuchowski N, Einstein D, Paushter D. Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 1994; 61:200–5.

    PubMed  CAS  Google Scholar 

  8. van Erkel A, van Gils A, Lequin M, Kruitwagen C, Bloem J, Falke T. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 1994; 18:432–8.

    PubMed  Google Scholar 

  9. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998; 171:201–4.

    PubMed  CAS  Google Scholar 

  10. Choyke P. ACR Appropriateness Criteria on Incidentally Discovered Adrenal Masses. J Am Coll Radiol 2006; 3:498–504.

    Article  PubMed  Google Scholar 

  11. Korobkin MF, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200:737–42.

    PubMed  CAS  Google Scholar 

  12. Korobkin MF, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170: 747–52.

    PubMed  CAS  Google Scholar 

  13. Blake MA, Krishnamoorthy SK, Boland GW, et al. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 2003; 181:1663–8.

    PubMed  Google Scholar 

  14. Jain RK, Munn LL, Fukumura D. Dissecting tumor pathophysiology using intravital microscopy. Nat Rev Cancer 2002; 2:266–76.

    Article  PubMed  CAS  Google Scholar 

  15. Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997; 202:693–6.

    PubMed  CAS  Google Scholar 

  16. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000; 175:1411–5.

    PubMed  CAS  Google Scholar 

  17. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798–802.

    PubMed  CAS  Google Scholar 

  18. Young WF. The incidentally discovered adrenal mass. N Eng J Med 2007; 356:601–10.

    Article  CAS  Google Scholar 

  19. Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP. Adrenal masses: CT characterization with histogram analysis method. Radiology 2003; 228:735–42.

    Article  PubMed  Google Scholar 

  20. Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR. CT histogram analysis in pathologically proven adrenal masses. AJR Am J Roentgenol 2006; 187:191–6.

    Article  PubMed  Google Scholar 

  21. Blake MA, Kalra MK, Maher MM, et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24:S87–99.

    Article  PubMed  Google Scholar 

  22. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 2004; 183:215–9.

    PubMed  Google Scholar 

  23. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. Radiographics 2001; 21:995–1012.

    PubMed  CAS  Google Scholar 

  24. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 2004; 231:711–716.

    Article  PubMed  Google Scholar 

  25. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 194:131–4.

    PubMed  CAS  Google Scholar 

  26. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy–initial experience. Radiology 2006; 238:970–7.

    Article  PubMed  Google Scholar 

  27. Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058–62.

    PubMed  Google Scholar 

  28. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the Evaluation of Adrenal Masses. J Nucl Med 2006; 47:32–37.

    PubMed  Google Scholar 

  29. Erasmus JJ, Patz EF, Jr., McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168:1357–60.

    PubMed  CAS  Google Scholar 

  30. Minn H, Salonen A, Friberg J, et al. Imaging of adrenal incidentalomas with PET using (11) C-metomidate and (18) F-FDG. J Nucl Med 2004; 45:972–9.

    PubMed  CAS  Google Scholar 

  31. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and. Endocr Rev 2004; 25:309–40.

    Article  PubMed  Google Scholar 

  32. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003; 138:424–9.

    PubMed  Google Scholar 

  33. Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005; 12:667–80.

    Article  PubMed  CAS  Google Scholar 

  34. Stone J. Incidentalomas–clinical correlation and translational science required. N Engl J Med 2006; 354:2748–9.

    Article  PubMed  CAS  Google Scholar 

  35. Blake MA, Sweeney AT, Kalra MK, Maher M. Collision Adrenal Tumors on PET/CT. Am J Roentgenol. 183(3):864–5, 2004.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Massachusetts General Hospital, 02114, Boston, MA, USA

    Michael A. Blake FFR (RCSI), FRCR, MRCPI & Mannudeep K. Kalra M.D., DNB

Authors
  1. Michael A. Blake FFR (RCSI), FRCR, MRCPI
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mannudeep K. Kalra M.D., DNB
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, 02114, Boston, MA, USA

    Michael A. Blake MRCPI  & Mannudeep K. Kalra M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Blake, M.A., Kalra, M.K. (2008). Current Status of Imaging for Adrenal Malignant Involvement. In: Blake, M.A., Kalra, M.K. (eds) Imaging in Oncology. Cancer Treatment and Research, vol 143. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75587-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-75587-8_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-75586-1

  • Online ISBN: 978-0-387-75587-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation